What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries
<p>Abstract</p> <p>As pharmaceutical expenditure continues to rise, third-party payers in most high-income countries have increasingly shifted the burden of payment for prescription drugs to patients. A large body of literature has examined the relationship between prescription cha...
| Main Authors: | Mossialos Elias, Thomson Sarah, Gemmill Marin C |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-05-01
|
| Series: | International Journal for Equity in Health |
| Online Access: | http://www.equityhealthj.com/content/7/1/12 |
Similar Items
-
Secular trends in premature and early menopause in low-income and middle-income countries
by: Tiziana Leone, et al.
Published: (2023-06-01) -
Equity in newborn care, evidence from national surveys in low- and middle-income countries
by: Kimberly Peven, et al.
Published: (2021-06-01) -
Essential packages of health services in low-income and lower-middle-income countries: what have we learnt?
by: Gavin Yamey, et al.
Published: (2023-01-01) -
Trauma registries in low- and middle-income countries: Working with what we already have
by: M.R. Kesinger, et al.
Published: (2014-09-01) -
Global consumption of prescription opioid analgesics between 2009-2019: a country-level observational study
by: Sahan Jayawardana, et al.
Published: (2021-12-01)